Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Shilpa Medicare

BSE: 530549|NSE: SHILPAMED|ISIN: INE790G01031|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 26, 16:00
698.90
-6.35 (-0.9%)
VOLUME 6,064
LIVE
NSE
Apr 26, 15:40
696.40
-8.45 (-1.2%)
VOLUME 21,674
Announcements on Shilpa

25th-Apr-2017 19:39Source: BSE

Shilpa- Certificate Under Reg.40 (9) Of SEBI (LODR) Regulations, 2015 For Half Year Ended 31St March, 2017.

With respect to the subject cited above, please find the attached Certificate issued under Reg.40 (9) of SEBI (LODR) Regulations, 2015, by M/s P.S.Rao & Associates, Company Secretaries, for the half y...

22nd-Apr-2017 11:59Source: BSE

Shilpa- Shareholding for the Period Ended March 31, 2017

Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly

18th-Apr-2017 17:18Source: BSE

Shilpa- Statement Of Investor Complaints For Period Ended 31.03.2017.

In Compliance with the requirement under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find below the statement of investor Complaints/Grievances ...

18th-Apr-2017 12:10Source: BSE

Shilpa- Compliance Certificate For The Period Ended 31St March, 2017.

With reference to the subject cited above, please find attached herewith the Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015, issued by the Company and the RTA i.e. M/s. ...

12th-Apr-2017 11:40Source: BSE

Shilpa- Updates

Sub: Intimation U/R 30 of the SEBI(LODR) Regulations- Reg. This is to inform you that the US FDA has issued an Establishment Inspection Report (EIR) for the Company''s Active Pharmaceutical Ingredien...

7th-Apr-2017 09:27Source: BSE

Shilpa- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dharmavathi Bhutada

6th-Apr-2017 19:02Source: BSE

Shilpa- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepak Kumar Inani

1st-Apr-2017 08:58Source: BSE

Shilpa- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Omprakash Inani

29th-Mar-2017 10:51Source: NSE

Shilpa Medicare Limited

Shilpa Medicare Limited has informed the Exchange regarding Notice of Court Covened General Meeting to be held on April 29, 2017.

28th-Mar-2017 20:49Source: BSE

Shilpa- Court Convened Meeting Of Shareholders' To Be Held On 29Th April,2017.

Notice is hereby given in pursuance of sub-section (5) of section 230 of the Companies Act, 2013, that as directed by the Bengaluru Bench of the National Company Law Tribunal at Bengaluru, by an order...

1 2 3 4 5 Next >>
Quick Links for Shilpa Medicare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.